Reagan Jarvis

Company: Anocca

Job title: Chief Executive Officer

Seminars:

T-Cell Receptor Targeting of Multiple RAS Mutant Forms in Broad Patient Populations 9:00 am

Characterization of RAS T-cell receptor (TCR) targets TCR discovery and characterization for multiple RAS mutations Challenge and propose of TCR-modified cell therapies targeting RAS mutationsRead more

day: Day Two